Status:
WITHDRAWN
Pyridoxal Kinase Activity in Tardive Dyskinesia
Lead Sponsor:
Beersheva Mental Health Center
Collaborating Sponsors:
Sha'ar Menashe Mental Health Center
Tirat Carmel Mental Health Center
Conditions:
Tardive Dyskinesia
Eligibility:
All Genders
18-65 years
Phase:
PHASE3
Brief Summary
Objectives: The mechanisms of tardive dyskinesia (TD) remain unclear, although pathophysiologic theories have proposed mechanisms such as dopamine receptor supersensitivity, the degeneration of cholin...
Eligibility Criteria
Inclusion
- Inpatients
- DSM-IV diagnosis of schizophrenia or schizoaffective disorder with and without tardive dyskinesia (TD)
- Total ESRS score should be more than 20 in subjects with TD
- Ability to provide a written informed consent
Exclusion
- Patients with concurrent medical illness or any movement disorder resemble TD
- Patients who received any vitamin medication
- Evidence of substance or alcohol abuse or a family history of movement disorder.
- Pregnancy and/or lactation.
Key Trial Info
Start Date :
July 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01908452
Start Date
July 1 2011
End Date
July 1 2011
Last Update
July 25 2013
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Be'er Sheva Mental Health Center
Beersheba, Israel, 84170
2
Sha'ar Menashe Mental Health Center
Hadera, Israel
3
Tirat Carmel Mental Health Center
Haifa, Israel